Table 3 Graft function after transplantation
From: Association of pre-transplant statin use with delayed graft function in kidney transplant recipients
Donor type | Graft function | Statin | Non-statin | Total | p-value |
|---|---|---|---|---|---|
|  |  | N = 92 | N = 174 | N = 266 |  |
All | Â | Â | Â | Â | 0.32 |
| Â | IGF | 31(34%) | 75(43%) | 106(40%) | 0.14 |
| Â | ND-DGF | 40(43%) | 63(36%) | 103(39%) | 0.25 |
| Â | D-DGF | 21(23%) | 36(21%) | 57(21%) | 0.69 |
Donation after Cardiac Death |  | N = 13 | N = 15 | N = 28 | 0.23 |
| Â | IGF | 0(0%) | 0(0%) | 0(0%) | Â |
| Â | ND-DGF | 4(31%) | 8(53%) | 12(43%) | Â |
| Â | D-DGF | 9(69%) | 7(47%) | 16(57%) | Â |
Donation after Brain Death |  | N = 49 | N = 94 | N = 143 | 0.80 |
| Â | IGF | 15(31%) | 27(29%) | 42(29%) | Â |
| Â | ND-DGF | 23(47%) | 41(43%) | 64(45%) | Â |
| Â | D-DGF | 11(22%) | 26(28%) | 37(26%) | Â |
Living Donor |  | N = 30 | N = 65 | N = 95 | 0.09 |
| Â | IGF | 16(54%) | 48(74%) | 64(68%) | Â |
| Â | ND-DGF | 13(43%) | 14(21%) | 27(28%) | Â |
| Â | D-DGF | 1(3%) | 3(5%) | 4(4%) | Â |